A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

June 12, 2020

Study Completion Date

September 24, 2020

Conditions
SARS CoV-2
Interventions
DIAGNOSTIC_TEST

Direct Antigen Tests for COVID-19

Rapid Antigen diagnostic device performance comparative to RT-PCR

Trial Locations (3)

33175

Kendall Regional, Miami

33180

Aventura Hospital and Medical Center, Miami

033401

JFK Medical Center, Miami

All Listed Sponsors
collaborator

SCRI Development Innovations, LLC

OTHER

lead

E25Bio, Inc.

INDUSTRY

NCT04568356 - A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests | Biotech Hunter | Biotech Hunter